United States · Wires & real time · Bloomberg

EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen

Published by Bloomberg · United States 2 h ago

EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing…

Read the full article on Bloomberg Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)

Also worth reading

PR Newswire

Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026

Associated Press (Business)

Why Rubio is visiting a small Indian city that’s home to world’s largest oil-refining complex

Business Wire

Accenture, Dragos and SANS Institute Launch Foundation to Strengthen Cyber Defenses for Under-Resourced U.S. Utilities

Dow Jones Newswires

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

MT Newswires